Wed, Feb 1, 2012 2:33 PM
Change in phone numbers
Change in the primary phone numbers at the main headquarters of the Company.

EGIS Pharmaceuticals PLC (the 'Company', having its headquarters at H-1106 Budapest, Keresztúri út 30-38.), hereby notifies stock market participants in compliance with its obligation pursuant to Sections 55-56 of the Act CXX of 2001 on the Capital Markets and to Section 1.17. of Enclosure 4 of the 24/2008. (VIII.15) Decree of the Minister of Finance about the change in the telephone contact details of the Company’s main headquarters.

Related file

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox